| Vol. 12.23 – 15 June, 2021 |
| |
|
|
| Researchers reported the largest and most diverse genetic study of type 1 diabetes to date, yielding 78 genome-wide-significant regions, including 36 that were new. [Nature Genetics] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Scientists showed that oncogenic KRAS promoted protein kinase C-mediated NAD+ kinase (NADK) phosphorylation, leading to its hyperactivation, thus sustaining both NADP+ and NADPH levels in pancreatic ductal adenocarcinoma cells. [Cell Reports] |
|
|
|
| Investigators showed that basic nitrogen-containing residues blocked central adverse events of dextromethorphan without reducing its anti-diabetic effects, including the protection of human pancreatic islets from cell death. [Cell Chemical Biology] |
|
|
|
| Researchers found that Ripk3−/− mice had significantly more severe pancreatic edema and inflammation associated with macrophage and neutrophil infiltration than control mice. [Cell Death & Disease] |
|
|
|
| Scientists provided a new cellular narrative for pancreatic development, homeostasis and response to injury via a small SET domain-containing protein 4 (SETD4)+ cell population. [Scientific Reports] |
| |
|
|
| Researchers show that silencing of endogenous mutp53 in KPC cells, derived from mouse PDAC tumors driven by mutant Kras and mutp53, down-regulated fibrosis and elevated CD8+ T cell infiltration in the tumors arising upon orthotopic injection of these cells into the pancreas of syngeneic mice. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Oncolytic viral chimera, CF33-hNIS-antiPDL1 genetically modified to express anti-human PD-L1 antibody and CF33-hNIS-Δ without the anti-PD-L1 gene, were used to investigate the immunogenic effects of oncolytic virus and virus-delivered anti-PD-L1 in pancreatic ductal adenocarcinoma in vitro. [Cancer Gene Therapy] |
|
|
|
| Scientists found that EPCAM + tumors developed in the mouse pancreas stored zinc that was detectable by fluorescence-activated cell sorting using N-(6-methoxy-8-quinolyl)-p-toluenesulfonamide (TSQ), a fluorescence chelator. EPCAM + TSQ + tumor cells isolated from the mouse pancreas formed organoids in matrigel. [Biological Trace Element Research] |
|
|
|
| Human pancreatic cancer cells MIA-Pa-Ca-2 were treated with the phytochemicals alone or their equimolar mixture for 24 hours and activation of Nrf2 and expression of its target genes were evaluated. [Nutrition and Cancer-An International Journal] |
| |
|
|
|
| The authors discuss recent advances in the understanding of the biological underpinnings of pancreatic ductal adenocarcinoma and their implications as targetable vulnerabilities in this highly lethal disease. [Genes & Development] |
|
|
|
| Investigators present a brief overview of vertebrate pancreas development, centered on Ptf1a function and transcriptional regulation, covering similarities and divergences in three broadly studied organisms: human, mouse, and zebrafish. [FEBS Journal] |
|
|
|
|
| DCB is looking for innovators, co-creators, scientists and members of the diabetes community from around the world to join our open call for ideas and be part of an innovative community at the forefront of diabetes technology. [Diabetes Center Berne (BusinessWire, Inc.)] |
|
|
|
|
| June 21 – 24, 2021 Virtual |
|
|
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Columbia University Irving Medical Center – New York, NY, United States |
|
|
|
| German Research Center for Environmental Health – Neuherberg, Germany |
|
|
|
| King’s College London – London, England, United Kingdom |
|
|
|
| Vertex Pharmaceuticals Incorporated – Watertown, New York, United States |
|
|
|
|